These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23202976)

  • 1. The role of neurotrophins in multiple sclerosis-pathological and clinical implications.
    Kalinowska-Lyszczarz A; Losy J
    Int J Mol Sci; 2012 Oct; 13(10):13713-25. PubMed ID: 23202976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinflammation and neuroprotection: an update on (future) neurotrophin-related strategies in multiple sclerosis treatment.
    De Santi L; Polimeni G; Cuzzocrea S; Esposito E; Sessa E; Annunziata P; Bramanti P
    Curr Med Chem; 2011; 18(12):1775-84. PubMed ID: 21466473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune cell NT-3 expression is associated with brain atrophy in multiple sclerosis patients.
    Kalinowska-Łyszczarz A; Pawlak MA; Michalak S; Paprzycki W; Losy J
    J Neuroimmunol; 2011 Dec; 240-241():109-13. PubMed ID: 22036954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive deficit is related to immune-cell beta-NGF in multiple sclerosis patients.
    Kalinowska-Łyszczarz A; Pawlak MA; Michalak S; Losy J
    J Neurol Sci; 2012 Oct; 321(1-2):43-8. PubMed ID: 22877509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fingolimod Increases Brain-Derived Neurotrophic Factor Level Secretion from Circulating T Cells of Patients with Multiple Sclerosis.
    Golan M; Mausner-Fainberg K; Ibrahim B; Benhamou M; Wilf-Yarkoni A; Kolb H; Regev K; Karni A
    CNS Drugs; 2019 Dec; 33(12):1229-1237. PubMed ID: 31713782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity.
    Moalem G; Gdalyahu A; Shani Y; Otten U; Lazarovici P; Cohen IR; Schwartz M
    J Autoimmun; 2000 Nov; 15(3):331-45. PubMed ID: 11040074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the role of nerve growth factor in multiple sclerosis: implications in myelin repair.
    Acosta CM; Cortes C; MacPhee H; Namaka MP
    CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1242-56. PubMed ID: 23844684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of neurotrophic factors in the pathology and treatment of multiple sclerosis.
    Mirowska-Guzel D
    Immunopharmacol Immunotoxicol; 2009; 31(1):32-8. PubMed ID: 18792835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-derived neurotrophic factor precursor in the immune system is a novel target for treating multiple sclerosis.
    Hu ZL; Luo C; Hurtado PR; Li H; Wang S; Hu B; Xu JM; Liu Y; Feng SQ; Hurtado-Perez E; Chen K; Zhou XF; Li CQ; Dai RP
    Theranostics; 2021; 11(2):715-730. PubMed ID: 33391501
    [No Abstract]   [Full Text] [Related]  

  • 10. What Guides Peripheral Immune Cells into the Central Nervous System?
    Greiner T; Kipp M
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroprotection in the treatment of multiple sclerosis].
    Zipp F; Gold R
    Nervenarzt; 2011 Aug; 82(8):973-7. PubMed ID: 21761185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Cell Neurotrophin Production Is Associated with Subcortical Brain Atrophy in Neuropsychiatric Systemic Lupus Erythematosus Patients.
    Kalinowska-Łyszczarz A; Pawlak MA; Wyciszkiewicz A; Pawlak-Buś K; Leszczyński P; Puszczewicz M; Paprzycki W; Kozubski W; Michalak S
    Neuroimmunomodulation; 2017; 24(6):320-330. PubMed ID: 29539621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelination.
    Linker R; Gold R; Luhder F
    Crit Rev Immunol; 2009; 29(1):43-68. PubMed ID: 19348610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies.
    van Noort JM; van den Elsen PJ; van Horssen J; Geurts JJ; van der Valk P; Amor S
    CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):68-81. PubMed ID: 21143143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between the cells of the immune and nervous system: neurotrophins as neuroprotection mediators in CNS injury.
    Tabakman R; Lecht S; Sephanova S; Arien-Zakay H; Lazarovici P
    Prog Brain Res; 2004; 146():387-401. PubMed ID: 14699975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research.
    Rottlaender A; Kuerten S
    Int J Mol Sci; 2015 Jul; 16(7):14850-65. PubMed ID: 26140377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms in the development of multiple sclerosis lesions: reconciling autoimmune and neurodegenerative factors.
    van Noort JM; Baker D; Amor S
    CNS Neurol Disord Drug Targets; 2012 Aug; 11(5):556-69. PubMed ID: 22583440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancing therapeutic options in multiple sclerosis with neuroprotective properties.
    Stroet A; Linker RA; Gold R
    J Neural Transm (Vienna); 2013 Sep; 120 Suppl 1():S49-53. PubMed ID: 23720188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ambivalent nature of T-cell infiltration in the central nervous system of patients with multiple sclerosis.
    Vanderlocht J; Hellings N; Hendriks JJ; Stinissen P
    Crit Rev Immunol; 2007; 27(1):1-13. PubMed ID: 17430093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.